For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, QuidelOrtho Corporation’s stock clocked out at $29.88, down -3.52% from its previous closing price of $30.97. In other words, the price has decreased by -$3.52 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
To gain a deeper understanding of QDEL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.76.
On December 11, 2024, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $44 to $50.
On December 10, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $43.Jefferies initiated its Hold rating on December 10, 2024, with a $43 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when The Bujarski 2007 Trust U/A Dt bought 100,200 shares for $47.50 per share.
Blaser Brian J. bought 6,033 shares of QDEL for $249,878 on Dec 11 ’24. The President and CEO now owns 6,033 shares after completing the transaction at $41.42 per share. On Dec 09 ’24, another insider, Robert Bujarski, who serves as the Former COO of the company, bought 20,000 shares for $40.40 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 0.67.
Stock Price History:
Over the past 52 weeks, QDEL has reached a high of $49.45, while it has fallen to a 52-week low of $23.77. The 50-Day Moving Average of the stock is 0.56%, while the 200-Day Moving Average is calculated to be -22.35%.
Shares Statistics:
A total of 67.50M shares are outstanding, with a floating share count of 66.22M. Insiders hold about 2.08% of the company’s shares, while institutions hold 111.68% stake in the company.
Earnings Estimates
QuidelOrtho Corporation (QDEL) is currently under the scrutiny of 6.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $0.7, with high estimates of $0.76 and low estimates of $0.57.
Analysts are recommending an EPS of between $2.49 and $2.27 for the fiscal current year, implying an average EPS of $2.39. EPS for the following year is $3.22, with 7.0 analysts recommending between $3.33 and $2.95.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $610.31M. It ranges from a high estimate of $613.7M to a low estimate of $604.56M. As of the current estimate, QuidelOrtho Corporation’s year-ago sales were $637MFor the next quarter, 7 analysts are estimating revenue of $693.74M. There is a high estimate of $703.8M for the next quarter, whereas the lowest estimate is $677.83M.
A total of 7 analysts have provided revenue estimates for QDEL’s current fiscal year. The highest revenue estimate was $2.74B, while the lowest revenue estimate was $2.7B, resulting in an average revenue estimate of $2.72B. In the same quarter a year ago, actual revenue was $2.78BBased on 8 analysts’ estimates, the company’s revenue will be $2.83B in the next fiscal year. The high estimate is $2.88B and the low estimate is $2.79B.
